United States Meningitis Vaccine Market Report 2017

May 2017 | 104 pages | ID: U93346AB14AEN
QYResearch

Abstracts

In this report, the United States Meningitis Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Meningitis Vaccine in these regions, from 2012 to 2022 (forecast).

United States Meningitis Vaccine market competition by top manufacturers/players, with Meningitis Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Baxter International
• Sanofi Pasteur
• Merck
• Novartis
• Pfizer
• Hualan
• Zhejiang Tianyuan
• Beijing Tiantan Biological

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Meningitis A+C
• Meningitis ACWY135
• Meningitis B

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Meningitis Vaccine for each application, including

• Medical Care
• Hospital

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Meningitis Vaccine Market Report 2017

1 MENINGITIS VACCINE OVERVIEW

1.1 Product Overview and Scope of Meningitis Vaccine
1.2 Classification of Meningitis Vaccine by Product Category
  1.2.1 United States Meningitis Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Meningitis Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Meningitis A+C
  1.2.4 Meningitis ACWY135
  1.2.5 Meningitis B
1.3 United States Meningitis Vaccine Market by Application/End Users
  1.3.1 United States Meningitis Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Medical Care
  1.3.3 Hospital
1.4 United States Meningitis Vaccine Market by Region
  1.4.1 United States Meningitis Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Meningitis Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Meningitis Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Meningitis Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Meningitis Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Meningitis Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Meningitis Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Meningitis Vaccine (2012-2022)
  1.5.1 United States Meningitis Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Meningitis Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES MENINGITIS VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Meningitis Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Meningitis Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Meningitis Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Meningitis Vaccine Market Competitive Situation and Trends
  2.4.1 United States Meningitis Vaccine Market Concentration Rate
  2.4.2 United States Meningitis Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Meningitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MENINGITIS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Meningitis Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Meningitis Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Meningitis Vaccine Price by Region (2012-2017)

4 UNITED STATES MENINGITIS VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Meningitis Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Meningitis Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Meningitis Vaccine Price by Type (2012-2017)
4.4 United States Meningitis Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES MENINGITIS VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Meningitis Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Meningitis Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES MENINGITIS VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Meningitis Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Baxter International
  6.2.2 Meningitis Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Baxter International Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi Pasteur
  6.3.2 Meningitis Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck
  6.4.2 Meningitis Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis
  6.5.2 Meningitis Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.2 Meningitis Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Hualan
  6.7.2 Meningitis Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Hualan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Zhejiang Tianyuan
  6.8.2 Meningitis Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Beijing Tiantan Biological
  6.9.2 Meningitis Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 MENINGITIS VACCINE MANUFACTURING COST ANALYSIS

7.1 Meningitis Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Meningitis Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Meningitis Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Meningitis Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MENINGITIS VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Meningitis Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Meningitis Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Meningitis Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Meningitis Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Meningitis Vaccine
Figure United States Meningitis Vaccine Market Size (K MT) by Type (2012-2022)
Figure United States Meningitis Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Meningitis A+C Product Picture
Figure Meningitis ACWY135 Product Picture
Figure Meningitis B Product Picture
Figure United States Meningitis Vaccine Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Meningitis Vaccine by Application in 2016
Figure Medical Care Examples
Figure Hospital Examples
Figure United States Meningitis Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Meningitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Meningitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Meningitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Meningitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Meningitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Meningitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Meningitis Vaccine Sales (K MT) and Growth Rate (2012-2022)
Figure United States Meningitis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Meningitis Vaccine Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Meningitis Vaccine Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Meningitis Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Meningitis Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Meningitis Vaccine Sales Share by Players/Suppliers
Figure United States Meningitis Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Meningitis Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Meningitis Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Meningitis Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Meningitis Vaccine Revenue Share by Players/Suppliers
Table United States Market Meningitis Vaccine Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Meningitis Vaccine Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Meningitis Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Meningitis Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Meningitis Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Meningitis Vaccine Product Category
Table United States Meningitis Vaccine Sales (K MT) by Region (2012-2017)
Table United States Meningitis Vaccine Sales Share by Region (2012-2017)
Figure United States Meningitis Vaccine Sales Share by Region (2012-2017)
Figure United States Meningitis Vaccine Sales Market Share by Region in 2016
Table United States Meningitis Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Meningitis Vaccine Revenue Share by Region (2012-2017)
Figure United States Meningitis Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Meningitis Vaccine Revenue Market Share by Region in 2016
Table United States Meningitis Vaccine Price (USD/MT) by Region (2012-2017)
Table United States Meningitis Vaccine Sales (K MT) by Type (2012-2017)
Table United States Meningitis Vaccine Sales Share by Type (2012-2017)
Figure United States Meningitis Vaccine Sales Share by Type (2012-2017)
Figure United States Meningitis Vaccine Sales Market Share by Type in 2016
Table United States Meningitis Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Meningitis Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Meningitis Vaccine by Type (2012-2017)
Figure Revenue Market Share of Meningitis Vaccine by Type in 2016
Table United States Meningitis Vaccine Price (USD/MT) by Types (2012-2017)
Figure United States Meningitis Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Meningitis Vaccine Sales (K MT) by Application (2012-2017)
Table United States Meningitis Vaccine Sales Market Share by Application (2012-2017)
Figure United States Meningitis Vaccine Sales Market Share by Application (2012-2017)
Figure United States Meningitis Vaccine Sales Market Share by Application in 2016
Table United States Meningitis Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Meningitis Vaccine Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Baxter International Basic Information List
Table Baxter International Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Baxter International Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Baxter International Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Baxter International Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Merck Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Novartis Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Novartis Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Pfizer Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Hualan Basic Information List
Table Hualan Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hualan Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Hualan Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Hualan Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Zhejiang Tianyuan Basic Information List
Table Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Zhejiang Tianyuan Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Zhejiang Tianyuan Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Zhejiang Tianyuan Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Beijing Tiantan Biological Basic Information List
Table Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Beijing Tiantan Biological Meningitis Vaccine Sales Growth Rate (2012-2017)
Figure Beijing Tiantan Biological Meningitis Vaccine Sales Market Share in United States (2012-2017)
Figure Beijing Tiantan Biological Meningitis Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Meningitis Vaccine
Figure Manufacturing Process Analysis of Meningitis Vaccine
Figure Meningitis Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Meningitis Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Meningitis Vaccine
Table Distributors/Traders List
Figure United States Meningitis Vaccine Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Meningitis Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Meningitis Vaccine Price (USD/MT) Trend Forecast (2017-2022)
Table United States Meningitis Vaccine Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Meningitis Vaccine Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Meningitis Vaccine Sales Volume (K MT) Forecast by Type in 2022
Table United States Meningitis Vaccine Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Meningitis Vaccine Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Meningitis Vaccine Sales Volume (K MT) Forecast by Application in 2022
Table United States Meningitis Vaccine Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Meningitis Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Meningitis Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Meningitis Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources